亚太地区干眼产品市场预测至 2031 年 - 区域分析 - 按产品(人工泪液、抗炎药物、泪点塞、促泌剂、口服 Omega 补充剂等)、剂型(眼药水、凝胶、胶囊和药片等)、类型(非处方药和处方药)和分销渠道(零售药店、医院药店和网上药店)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)


No. of Pages: 117    |    Report Code: TIPRE00028846    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Dry Eye Products Market
2023 年亚太地区干眼症产品市场价值为 11.0146 亿美元,预计到 2031 年将达到 16.4184 亿美元;预计 2023 年至 2031 年的复合年增长率为 5.1%。

不断增加的眼部护理意识举措推动亚太干眼症产品市场发展

近年来,人们采取了各种举措来提高对眼部疾病的认识和教育,促使患者获得合适的药物和治疗。例如,作为可避免失明计划 (ABP)(2021 年启动)的一部分,诺华与其在撒哈拉以南非洲和东南亚的合作伙伴合作,于 2022 年让患者能够使用其眼部护理产品。ABP 专注于由青光眼和视网膜疾病引起的中度至重度视力损伤,这些疾病是造成很大一部分可预防失明的原因。

国际防盲机构 (IAPB) 于 2022 年发起了名为“爱护您的眼睛”的全球运动,以提高人们对眼部健康社会经济重要性的认识。该运动呼吁各国政府和全球机构支持眼部健康。IAPB 强调印度和世界各地的计划和举措,这些计划和举措迅速专注于提供方便、可用且负担得起的眼部护理。“爱护您的眼睛”计划还呼吁改变法规并筹集资金,以使眼部护理在 2030 年前变得方便、可用且负担得起。

2022 年 12 月,防盲研究选择了犹他大学的 John A. Moran 眼科中心,每年提供 115,000 美元的无限制资助,以支持眼部研究。截至 2021 年 12 月,美国国立卫生研究院 (NIH) 支持印度阿拉文眼科医院和凯洛格眼科中心之间的合作,为眼科护理专业人员开发临床研究培训计划。作为该计划的一部分,美国国立卫生研究院拨款 110 万美元支持安阿伯 (美国) 的培训计划,并为参与者提供种子资金。此外,2020 年印度-美国合作视觉研究计划侧重于推进科学和技术,以了解、预防和治疗致盲性视觉障碍、眼部疾病及其相关并发症。印度生物技术部和美国国家眼科研究所资助了这项研究计划。

因此,增加用于眼保健研究的资金和不断增加的传播眼保健意识的举措可能会在未来几年为干眼产品市场创造新的机会。

亚太干眼产品市场概览

亚太干眼产品市场分为中国、印度、日本、韩国、澳大利亚和亚太其他地区。可能促成该地区市场增长的因素包括由于长时间使用电脑导致年轻人干眼症发病率增加、政府对眼保健的支持不断增加以及眼科解决方案的不断发展。根据美国国立卫生研究院的数据,在中国,每年约有 20-30% 的人被诊断出患有干眼症。中国的干眼产品市场竞争相当激烈,国内外制药公司都参与其中。Novaliq 与江苏恒瑞医药建立了战略合作关系,共同生产、开发和商业化用于治疗干眼症的 NOV03。2021 年 12 月,恒瑞从 SHR8058(NOV03)治疗与睑板腺功能障碍相关的干眼症的关键 3 期临床试验中获得了积极成果;该试验在中国 17 个地点进行。这家中国公司预计将在中国和东南亚分销这些产品。

亚太干眼产品市场收入和预测到 2031 年(百万美元)

亚太干眼产品市场细分

亚太干眼产品市场分为产品、剂型、类型、分销渠道和国家。

根据产品,亚太干眼产品市场细分为人工泪液、抗炎药、泪点塞、促泌剂、口服欧米茄补充剂等。人工泪液部分在 2023 年占据了亚太干眼产品市场的最大份额。此外,抗炎药部分细分为环孢菌素、皮质类固醇等。此外,泪点塞部分细分为可溶解和可拆卸。

就剂型而言,亚太干眼产品市场细分为眼药水、凝胶、胶囊和片剂等。眼药水部分在 2023 年占据了亚太干眼产品市场的最大份额。

按类型,亚太干眼产品市场分为非处方药和处方药。 2023 年,非处方药部门在亚太地区干眼产品市场占有较大的份额。

根据分销渠道,亚太地区干眼产品市场分为零售药店、医院药店和在线药店。2023 年,零售药店部门在亚太地区干眼产品市场占有最大的份额。

根据国家/地区,亚太地区干眼产品市场分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。2023 年,中国占据了亚太地区干眼产品市场的主导地位。

参天制药有限公司、强生公司、OASIS Medical、URSAPHARM Arzneimittel GmbH、乐敦制药有限公司、OCuSOFT Inc、博士伦健康公司、艾伯维公司、Prestige Consumer Healthcare Inc、Farmigea SpA 和爱尔康公司是亚太地区干眼产品市场的一些领先公司。

Asia Pacific Dry Eye Products Strategic Insights

Strategic insights for Asia Pacific Dry Eye Products involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-dry-eye-products-market-strategic-framework.webp
Get more information on this report

Asia Pacific Dry Eye Products Report Scope

Report Attribute Details
Market size in 2023 US$ 1,101.46 Million
Market Size by 2031 US$ 1,641.84 Million
Global CAGR (2023 - 2031) 5.1%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品
  • 人工泪液
  • 抗炎药
  • 泪点塞
  • 促泌剂
  • 口服欧米茄补充剂
By 剂型
  • 眼药水
  • 凝胶
  • 胶囊
  • 药片
By 类型
  • OTC,处方
By 分销渠道
  • 零售药店
  • 医院药店
  • 网上药店
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Santen Pharmaceutical Co Ltd
  • Johnson & Johnson
  • OASIS Medical
  • URSAPHARM Arzneimittel GmbH
  • Rohto Pharmaceutical Co Ltd
  • OCuSOFT Inc.
  • Bausch Health Companies Inc
  • AbbVie Inc
  • Prestige Consumer Healthcare Inc.
  • Farmigea SpA
  • Get more information on this report

    Asia Pacific Dry Eye Products Regional Insights

    The regional scope of Asia Pacific Dry Eye Products refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-dry-eye-products-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Dry Eye Products Market

    1. Santen Pharmaceutical Co Ltd
    2. Johnson & Johnson
    3. OASIS Medical
    4. URSAPHARM Arzneimittel GmbH
    5. Rohto Pharmaceutical Co Ltd
    6. OCuSOFT Inc.
    7. Bausch Health Companies Inc
    8. AbbVie Inc
    9. Prestige Consumer Healthcare Inc.
    10. Farmigea SpA
    11. Alcon AG
    Frequently Asked Questions
    How big is the Asia Pacific Dry Eye Products Market?

    The Asia Pacific Dry Eye Products Market is valued at US$ 1,101.46 Million in 2023, it is projected to reach US$ 1,641.84 Million by 2031.

    What is the CAGR for Asia Pacific Dry Eye Products Market by (2023 - 2031)?

    As per our report Asia Pacific Dry Eye Products Market, the market size is valued at US$ 1,101.46 Million in 2023, projecting it to reach US$ 1,641.84 Million by 2031. This translates to a CAGR of approximately 5.1% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Dry Eye Products Market report typically cover these key segments-

  • 产品 (人工泪液, 抗炎药, 泪点塞, 促泌剂, 口服欧米茄补充剂)
  • 剂型 (眼药水, 凝胶, 胶囊, 药片)
  • 类型 (OTC,处方)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Dry Eye Products Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Dry Eye Products Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
  • Who are the major players in Asia Pacific Dry Eye Products Market?

    The Asia Pacific Dry Eye Products Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Santen Pharmaceutical Co Ltd
  • Johnson & Johnson
  • OASIS Medical
  • URSAPHARM Arzneimittel GmbH
  • Rohto Pharmaceutical Co Ltd
  • OCuSOFT Inc.
  • Bausch Health Companies Inc
  • AbbVie Inc
  • Prestige Consumer Healthcare Inc.
  • Farmigea SpA
  • Alcon AG
  • Who should buy this report?

    The Asia Pacific Dry Eye Products Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Dry Eye Products Market value chain can benefit from the information contained in a comprehensive market report.